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INTRODUCTION
In this context, s-triazine scaffold has attracted the attention of many researchers for its therapeutic potential [1] and ease of functionalization on it [2, 3] . For example, these compounds possess potent antiprotozoal [4] antimalarial [5, 6] antiviral [7] [8] [9] anticancer [10, 11] antimicrobial [12] [13] [14] anti-tuberculosis [15, 16] . Recently, significant therapeutic potential for central nervous system (CNS) disorders. 1,3,4-thiadiazole derivatives have been reported to exhibit a wide range of pharmacological effects including analgesic, antidepressant, anxiolytic and anticonvulsant activities. The sulfur atom of thiadiazole ring imparts improved liposolubility, important for the drugs active at CNS level. The mesoionic nature of 1,3,4-thiadiazoles allows these compounds to cross cellular membranes and interact with biological targets with distinct affinities [23] [24] [25] [26] [27] [28] [29] [30] [31] . Considering the potent bioactivities of compounds possessing an s-triazine core, we became interested to synthesize new s-triazine derivatives as antibacterial agents. In continuation to the previous work, we herein report newer s-triazine derivatives appended with 1,2,4-triazine and thiadiazole derivatives. Synthesized compounds were screened against antibacterial and anti fungal activity.
EXPERIMENTAL

Materials and Physical Measurements
All reactions except those in aqueous media were carried out by standard techniques for the exclusion of moisture. Melting points were determined on an electro thermal melting point apparatus and are reported uncorrected. TLC on silica gel plates were used for purity checking and reaction monitoring. Elemental analysis (% C, H, N) was carried out by a Perkin-Elmer 2400 CHN analyzer. IR spectra of all compounds were recorded on a Perkin-Elmer FT-IR spectrophotometer in KBr. 1 HNMR spectra were recorded on Bruker Avance II-400 MHz and 13 CNMR spectra on Bruker Avance II-400, 100 MHz in DMSO-d6 as a solvent and tetramethylsilane (TMS) as an internal standard. Mass spectra were recorded on triple quadrapole LCMS-6410 from Agilent Technology.
Preparation of 4,6-dichloro-N-phenyl-1,3,5-triazin-2-amine: (P1)
To a stirred solution of cyanuric chloride (0.01 mol) in acetone (25 mL) at 0-5 ºC, the solution of primary amine solution (0.01 mol) in acetone (15 mL) was added and pH being maintained neutral by the addition of 10% sodium bicarbonate solution from time to time as per requirement of reaction condition. The stirring was continued at 0-5 ºC for 2 hours. After the completion of reaction the stirring was stopped and the solution was treated with crushed ice. The solid product obtained was filtered and dried. To a stirred solution of (P1) (0.01 mol) in DMF (25 mL) was added , the solution of 5-benzyl-1,3,4-thiadiazol-2-amine (0.01 mol) in DMF (15 mL) was added drop wise maintaining the temperature at 40 C, the pH being maintained neutral by the addition of 10% sodium bi-carbonate solution from time to time as per requirement of reaction condition. The temperature was gradually raised to 45 ºC during three hours. After the completion of reaction, the resultant content was poured into ice-cold water. The solid product obtained was filtered and dried. 
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